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1. Introduction 
The amelanotic hamster melanoma is a very rapidly 
growing tumor which leads in less than 18 days after 
subcutaneous transplantation to the death of the ani- 
mal. The rapid growth of this tumor implies a high nu- 
cleic acid and protein synthesizing activity. Studies have 
been undertaken to find agents which can influence 
this hyperactivity and reduce the tumor growth without 
affecting the host cells. Several reports have been pu- 
blished on growth retardation of melanoma by drugs 
[1-4] but only a few have been concerned with the 
influence of these drugs on nucleic acid and protein 
synthesis [5,6]. Preliminary experiments from our 
laboratory indicated that neither chloramphenicol nor 
D-penicillamine affected the tumor. However, using the 
acridine dye proflavine we found some remarkable 
growth retardation [7]. Our recent studies on the incor- 
poration rate of 3 H-thymidine into nuclear and mito- 
chondrial DNA of the melanoma in the presence of 
proflavine let us assume that this dye has an inhibitory 
effect on the DNA synthesis [8]. Inhibition of RNA- 
polymerase from this tumor by proflavine in vitro and 
in vivo could also be demonstrated [9]. 
The effects of acridine dyes on the metabolism of 
animal cells are well documented and broadly resemble 
those produced by actinomycin D; the synthesis of 
RNA is strongly inhibited and the synthesis of protein 
relatively unaffected [ 10-13 ]. However, we suspected 
that the inhibition of DNA and RNA synthesis in the 
melanoma by proflavine may not completely account 
for the observed growth retardation. Therefore the 
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purpose of the experiments described in this paper 
was to investigate the influence of proflavine on the 
protein synthesizing machinery of the melanoma cells. 
2. Materials and methods 
The amelanotic hamster melanoma, described by 
Fortner [ 14] wasgenerously supplied by Priv.Doz.Dr.D. 
Gericke (Leiter der Abteilung ffir Tumorforschung der 
Farbwerke Hoechst AG., Frankfurt am Main). The tu- 
mors were serially transplanted subcutaneously into 
female Syrian hamster weighing 60-80 g. On the tenth 
day after transplantation 100 mg proflavine (Fluka, 
Buchs, SG., Schweiz) per kg bodyweight dissolved 
in isotonic NaC1 solution was applied intraperito- 
neally to a group of 4 animals. After 60 min the 
proflavine treated animals together with 4 control 
hamsters received 20/aCi/animal of 3H-phenylalanine 
(Radiochemical Centre, Amersham England; specific 
activity 21 Ci/mmole). A chase of a 5000 fold 
excess of cold phenylalanine was applied after one or 
3 hr respectively. The animals were killed 20 min after 
injection of the chase. Tumors and livers of all animals 
were carefully dissected, washed and homogenized. 
Nuclei and mitochondria of both sources were pre- 
pared and purified as previously described [7]. The 
mitochondrial supernatant was centrifuged for 1 hr 
at 144,000g. The pellet was regarded as the micro- 
somal fraction and the supernatant of the microsomes 
as cytoplasm. In all these cell fractions the specific 
radioactivity was determined and the inhibition of the 
incorporation rate by proflavine was calculated. 
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Table 1 
Incorporation rate of 3H-phenylalanine after 60 min into nuclear, mitochondrial, microsomal nd cytoplasmic proteins of melanoma 
and liver in the presence and absence of proflavine. 
Cell fraction Condition 
Melanoma Liver 
Specific radio- % Inhibition by Specific radio- % Inhibition by 
activity proflavine activity proflavine 
untreated 185.0 - 450.0 - Nuclei 
proflavine treated 16.0 91.5 335.0 25.0 
untreated 210.0 - 1050.0 - Mitochondria 
proflavine treated 22.0 89.5 840.0 20.0 
untreated 140.0 - 480.0 - 
Microsomes proflavine treated 13.7 90.2 445.0 7.0 
untreated 165.0 - 478.0 - 
Cytoplasm proflavine treated 19.8 88.0 405.0 15.0 
3. Results and discussion 
The incorporation of a H-phenylalanine during a 60 
minute period into nuclear, mitochondrial, microsomal 
and cytoplasmic proteins from melanoma nd liver is 
shown in table 1. The cell fractions of the liver exhibit 
a 2.5 fold higher incorporation rate than the tumor 
fractions except for the mitochondria. The labelling of 
the tumor mitochondria is only one fifth of  that of the 
liver mitochondria. This might be due to differences 
in the extrinsic and intrinsic contribution to the forma- 
tion of intact mitochondria of melanoma or liver. Pre- 
liminary studies of  the electrophoretic pattern of the 
mitochondria, showing significant differences between 
the mitochondria of both sources [15], support his 
view. 
Treatment of the tumor-bearing animals with profla- 
vine 60 minutes before injection of the radioactivity, 
results in an inhibition of the incorporation rate in all 
cell components of the melanoma. The highest inhibi- 
tion (91.5%) is found for the nuclear protein but the 
inhibition was about the same in the cell components 
studied. However, the incorporation rate of phenylala- 
nine into the liver fractions was dramatically less inhi- 
bited by the proflavine treatment. The highest inhibition 
was found in the nuclear protein (25%), the lowest in 
the microsomal fraction (7%).(see also table 1). 
Prolongation of the incorporation time of 3 H-phenyl- 
alanine from 60 to 180 min resulted in an increase of the 
specific activity in all cell components of the melanoma 
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and the liver, although the increase was remarkably 
higher in the tumor (table 2). The inhibition by profla- 
vine remained the same in the melanoma whether 
measured 120 or 240 min after injection of  the drug. 
However, an increase in proflavine inhibition was 
observed for the liver fractions after 240 min of treat- 
ment. This effect corresponds to an increase in the 
proflavine content of the liver fractions. The proflavine 
concentration, asestimated by the absorption of  this 
dye at 450 nm, was 120 minutes after application 100 
nmoles/mg protein in the liver nuclei and about 10 
nmoles/mg protein in the other cell components as 
mitochondria, microsomes and cytoplasm. After 240 
minutes the proflavine concentration i creased in the 
mitochondria, microsomes and cytoplasm to somewhat 
more than twofold. It should also be mentioned that the 
actual proflavine content in the cell fractions of the 
melanoma t both times was less than 2.5% of that 
found in the liver fractions. If we assume proportio- 
nality of the proflavine ffect, the inhibition of phenyl- 
alanine incorporation i to the liver would be even smal- 
ler than stated in table 1. When considered for the same 
proflavine content as that found in the tumor the pro- 
flavine inhibition in mitochondria, microsomes and 
cytoplasm of liver might be calculated as 0.5%. These 
results uggest hat a protein synthesizing system exists 
in the melanoma, which can be differentiated from the 
system normally found in eucaryotic ells by its pro- 
flavine sensitivity. 
The highly proflavine-sensitive protein synthesis in 
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Table 2 
Incorporation rate of 3H-phenylalanine after 180 min into nuclear, mitochondrial, microsomal nd cytoplasmic proteins of mela- 
noma and liver in the presence and absence of proflavine. 
Cell fraction Condition 
Melanoma Liver 
Specific radio- % Inhibition by Specific radio- % Inhibition by 
activity proflavine activity proflavine 
untreated 1410.0 - 1380.0 - 
Nuclei 
proflavine treated 80.0 94.5 650.0 53.0 
untreated 1580.0 - 1920.0 - 
Mitochondria 
proflavine treated 174.0 89.0 920.0 52.0 
untreated 1730.0 - 3460.0 - Microsomes 
proflavine treated 176.0 89.8 1580.0 54.0 
untreated 1550.0 - 1400.0 - 
Cytoplasma proflavine treated 145.0 90.6 740.0 47.0 
the melanoma might be a tumor-specific one which may 
be coded for by tumor-specific RNA species, derived 
from a messenger of foreign origin. A search is now 
being made to identify tumor-specific proteins in the 
melanoma by their proflavine sensitivity, to characte- 
rize their functions and to find out in which cell com- 
ponents they are localized. 
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